WeVote
Log In

Bill

Bill

HB 1186

TO CREATE THE PAIN RELIEF PARITY ACT; AND TO REQUIRE PAIN RELIEF PARITY IN THE ARKANSAS MEDICAID PROGRAM.

2025 Regular Session Introduced by Clint Penzo and 1 co-sponsor

Arkansas requires Medicaid to provide equal coverage and reimbursement for opioid and non-opioid pain management treatments to improve patient access and treatment options.

Notification that HB1186 is now Act 960
0
WeVote Research Nonpartisan
Bill Summary · HB 1186

Legislative bill overview

HB 1186, now Act 960, establishes the Pain Relief Parity Act requiring Arkansas Medicaid to provide equal coverage and reimbursement for pain management treatments. The law mandates that opioid and non-opioid pain relief options receive equivalent authorization processes, coverage criteria, and payment rates to ensure patients have equitable access to all medically appropriate pain management modalities.

Why is this important

Pain management coverage disparities can limit patient treatment options and physician prescribing discretion, potentially forcing reliance on opioids when non-opioid alternatives might be more appropriate. This bill addresses growing concerns about Medicaid formulary restrictions that may inadvertently incentivize opioid use by making alternatives harder to access or more costly, with implications for chronic pain patients, addiction prevention, and state healthcare spending.

Potential points of contention

  • Cost implications: Expanding coverage parity may increase state Medicaid expenditures if non-opioid therapies (physical therapy, interventional procedures, newer medications) cost more, creating budget pressures
  • Clinical complexity: "Parity" in formularies is medically nuanced—opioids and non-opioid treatments serve different patient populations and conditions, making strict parity difficult to implement without clinical guidance
  • Implementation ambiguity: The bill's language regarding equal "authorization processes" and "reimbursement rates" lacks specifics on how Medicaid will operationalize parity across diverse treatment types with different evidence bases and cost structures

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.